AKE 0.00% $9.83 allkem limited

Allkem General Discussion, page-1454

  1. 779 Posts.
    lightbulb Created with Sketch. 1086
    Agree this is likely undervalued based on pricing being achieved.

    JB is not approved and is years away from producing spod.
    Naraha should have been commissioned many months ago. Oz2 has been delayed and inevitably Naraha.
    Can has been kicked down the road on various fronts.

    Lithium pricing thematic will only push the sails so far, eventually the company needs to start delivering.

    What is needed are updates from the company on progress across various projects, not having to rely on sentinel images to check progress of pond lining. Approvals / permitting, offtake strategy / partnerships, construction completion % and anticipated ramp up etc etc.

    Why not setup a partnership in Europe or NA akin to Naraha to feed a growing market, leveraging the company's market leading asset base and technical know how. Decouple from Toyota, add some competitive tension for both speed of execution and pricing leverage.

    Quarterly updates on price and production are nice but hardly needle moving. Execution risk remains the biggest driver imo and that is an area where the company has a checkered past, albeit somewhat jusfitiable.

    Aimo
 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.